NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets stubborn blood cancers in early trial
Disease control Recruiting nowThis study is testing two experimental drugs, APG-115 and APG-2575, in people with certain blood cancers (T-PLL or NHL) that have come back or stopped responding to treatment. The goal is to find safe doses and see if the drugs can control the disease. About 78 adults will take p…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug, MK-1026 (nemtabrutinib), in people with certain blood cancers like chronic lymphocytic leukemia, lymphoma, and Waldenstrom's macroglobulinemia. The goal is to see if the drug can shrink tumors and control the disease. About 490 adults w…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:53 UTC